LABP - Landos Biopharma GAAP EPS of -$0.63 August, 10 2023 02:20 PM Landos Biopharma Inc. 2023-08-10 14:20:32 ET Landos Biopharma press release ( NASDAQ: LABP ): Q2 GAAP EPS of -$0.63. the Company had cash, cash equivalents and marketable securities of $44.7 million, For further details see: Landos Biopharma GAAP EPS of -$0.63